Rivus Pharmaceuticals Announces Completion of Enrollment in Phase 2a HuMAIN Trial of HU6

/PRNewswire/ -- Rivus Pharmaceuticals Inc., a clinical-stage biopharmaceutical company dedicated to improving cardiometabolic health, today announced the...

Related Keywords

San Francisco ,California ,United States ,Gastroenterol Hepatol ,Meredith Mallen ,Prnewswire Rivus Pharmaceuticals Inc ,Rivus Pharmaceuticals ,Francis Hotel ,Rivus Pharmaceuticals Inc ,Healthcare Conference ,Pharmaceuticals Inc ,Jayson Dallas ,Healthcare Conference Presentation Details ,Controlled Metabolic Accelerators ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Pharmaceuticals ,Clinical Trials Amp Medical Discoveries ,